Company logo

PBH - Prestige Consumer Healthcare Inc.

NYSE -> Healthcare -> Medical Distribution
Tarrytown, United States
Type: Equity

PBH price evolution
PBH
(in millions $) 30 Oct 2024 30 Jul 2024 1 May 2024 31 Jan 2024
Current assets
Cash $63.62
Short term investments
Net receivables $174.29
Inventory $148.64
Total current assets $393.79
Long term investments
Property, plant & equipment $83.26
Goodwill & intangible assets $2856.41
Total noncurrent assets $2945.97
Total investments
Total assets $3339.75
Current liabilities
Accounts payable $39.34
Deferred revenue
Short long term debt $7.84
Total current liabilities $127.44
Long term debt $1205.67
Total noncurrent liabilities $1611.74
Total debt $1213.51
Total liabilities $1739.18
Shareholders' equity
Retained earnings $1291.74
Other shareholder equity -$28.53
Total shareholder equity $1600.58
(in millions $) 31 Dec 2023 31 Dec 2022 31 Dec 2021 31 Dec 2020
Current assets
Cash $58.49 $27.18 $32.3 $94.76
Short term investments
Net receivables $167.02 $139.33 $114.67 $150.52
Inventory $162.12 $120.34 $114.96 $116.03
Total current assets $391.74 $293.27 $269.83 $365.65
Long term investments
Property, plant & equipment $89.53 $98.53 $102.77 $90.72
Goodwill & intangible assets $2869.45 $3275.61 $3053.81 $3054.57
Total noncurrent assets $2961.99 $3377.41 $3159.44 $3148.25
Total investments
Total assets $3353.73 $3670.68 $3429.27 $3513.91
Current liabilities
Accounts payable $62.74 $55.76 $45.98 $62.38
Deferred revenue
Short long term debt $9.76 $9.11 $8.45 $6.83
Total current liabilities $160.72 $143.42 $122.14 $149.88
Long term debt $1357.33 $1497.25 $1506.17 $1759.8
Total noncurrent liabilities $1745.93 $1949.65 $1948.84 $2193.05
Total debt $1367.09 $1506.36 $1514.62 $1766.63
Total liabilities $1906.64 $2093.07 $2070.97 $2342.93
Shareholders' equity
Retained earnings $1131.86 $1214.16 $1008.78 $844.1
Other shareholder equity -$31.56 -$19.03 -$19.8 -$44.16
Total shareholder equity $1447.08 $1577.61 $1358.3 $1170.97
(in millions $) 30 Oct 2024 30 Jul 2024 1 May 2024 31 Jan 2024
Revenue
Total revenue
Cost of revenue
Gross Profit
Operating activities
Research & development
Selling, general & administrative
Total operating expenses
Operating income
Income from continuing operations
EBIT
Income tax expense
Interest expense
Net income
Net income
Income (for common shares)
(in millions $) 31 Dec 2023 31 Dec 2022 31 Dec 2021 31 Dec 2020
Revenue
Total revenue $1127.72 $1086.81 $943.37 $963.01
Cost of revenue $502.43 $466.17 $395.89 $410.79
Gross Profit $625.29 $620.65 $547.47 $552.22
Operating activities
Research & development
Selling, general & administrative $252.41 $265.86 $226.13 $236.31
Total operating expenses $647.71 $290.73 $250.07 $261.07
Operating income -$22.41 $329.92 $297.4 $291.15
Income from continuing operations
EBIT -$24.75 $326.75 $286.44 $287.72
Income tax expense -$11.61 $57.08 $39.43 $48.87
Interest expense $69.16 $64.29 $82.33 $96.57
Net income
Net income -$82.31 $205.38 $164.68 $142.28
Income (for common shares) -$82.31 $205.38 $164.68 $142.28
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 31 Mar 2023
Net income $53.05 $53.56 $53.28 -$240.55
Operating activities
Depreciation $9.32 $9.21 $8.79 $9.48
Business acquisitions & disposals
Stock-based compensation $2.45 $3.69 $4.15 $2.65
Total cash flows from operations $71.47 $62.46 $48.09 $58.99
Investing activities
Capital expenditures -$2 -$2.93 -$1.48 -$2.56
Investments
Total cash flows from investing -$4.5 -$2.93 $2.32 -$6.36
Financing activities
Dividends paid
Sale and purchase of stock $1.64 $2.15 -$17.97 $0.2
Net borrowings -$66.48 -$55.7 -$30.7 -$80.69
Total cash flows from financing -$64.84 -$53.55 -$54.18 -$80.5
Effect of exchange rate $1.42 -$0.49 -$0.14 -$0
Change in cash and equivalents $3.55 $5.49 -$3.91 -$27.87
(in millions $) 31 Dec 2023 31 Dec 2022 31 Dec 2021 31 Dec 2020
Net income -$82.31 $205.38 $164.68 $142.28
Operating activities
Depreciation $38.94 $38.8 $37.25 $37.78
Business acquisitions & disposals -$247.05
Stock-based compensation $12.4 $9.04 $8.54 $7.64
Total cash flows from operations $229.72 $259.92 $235.61 $217.12
Investing activities
Capital expenditures -$7.78 -$9.64 -$22.24 -$14.56
Investments
Total cash flows from investing -$11.58 -$256.51 -$22.24 -$16.57
Financing activities
Dividends paid
Sale and purchase of stock -$42.63 $7.04 -$9.02 -$55.4
Net borrowings -$137.75 -$5.58 -$251.44 -$68.48
Total cash flows from financing -$185.85 -$7.57 -$279.42 -$131.43
Effect of exchange rate -$0.98 -$0.96 $3.6 -$1.89
Change in cash and equivalents $31.3 -$5.12 -$62.46 $67.23
Fundamentals
Market cap N/A
Enterprise value N/A
Shares outstanding N/A
Revenue N/A
EBITDA N/A
EBIT N/A
Net Income N/A
Revenue Q/Q N/A
Revenue Y/Y N/A
P/E ratio N/A
EV/Sales N/A
EV/EBITDA N/A
EV/EBIT N/A
P/S ratio N/A
P/B ratio N/A
Book/Share N/A
Cash/Share N/A
EPS N/A
ROA N/A
ROE N/A
Debt/Equity 1.32
Net debt/EBITDA N/A
Current ratio N/A
Quick ratio N/A